Solesence, Inc. (SLSN) stock
Close on Nov 12, 2026Market cap $64.22MP/E 22.7Yield –
Solesence, Inc. saw revenue fall 2.0% to $60.94M over the twelve months to Sep 30, 2026. Operating income rose 437.4% to $3.68M, moving the operating margin from 1.1% to 6.0%. At the latest close the market valued the company at $64.22M, 22.7 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $64.22M
- P/E ratio
- 22.7
- Price to sales
- 1.05
- Price to book
- 3.83
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $60.94M
- Net income
- $2.75M
- EPS, diluted
- $0.04
- Book value per share
- $0.23
- Diluted shares
- 71M
Trading
- Next earnings
- Nov 12, 2026 (estimated, after the close)
- Previous close
- $0.91
- Open
- $0.88
- Day's range
- $0.88 – $0.91
- Volume
- 1,672,789
- Average volume (20 days)
- 105,898
- Index membership
- Russell 2000 (since Jun 2025)
- Beta (5 years)
- 1.34
- 52-week range
- $0.61 – $2.39
- RSI (14 days)
- 55.9
- Volatility (1 year)
- 106.3%
- Relative volume
- 0.54×
- WACC
- 11.6%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SLSN | S&P 500 | Difference | SLSN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.1% | -2.7% | −6.4 pts | ||
| 3 months | -13.4% | -1.7% | −11.7 pts | ||
| Year to date | -43.0% | +11.9% | −54.9 pts | ||
| 1 year | -53.1% | +12.0% | −65.1 pts | ||
| 3 years | -5.3% | +78.2% | −83.5 pts | -1.8% | +21.2% |
| 5 years | -76.6% | +73.2% | −149.8 pts | -25.2% | +11.6% |
| 10 years | +39.8% | +309.6% | −269.8 pts | +3.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Solesence filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Solesence
Perfumes, Cosmetics & Other Toilet Preparations
Solésence, Inc. develops and manufactures mineral-based skin health, sun care, and cosmetic products, as well as active pharmaceutical ingredients and legacy advanced materials. The company vertically integrates proprietary particle surface treatment and dispersion technologies to produce market-ready, customized white-label, and custom-formulated finished goods, including sunscreens, color cosmetics, and skin care formulations. Additionally, it produces engineered zinc oxide and titanium dioxide ingredients. Solésence serves global prestige beauty and personal care brand partners, alongside corporate customers such as chemical manufacturers.
Company profile, executives and historySolesence stock: common questions
What is Solesence's stock price?
SLSN closed at $0.91 on Nov 12, 2026, down 0.22% on the day. Over the past 52 weeks it traded between $0.61 and $2.39.
What is Solesence's market cap?
Solesence was worth $64.22M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is SLSN's P/E ratio?
SLSN trades at 22.7 times earnings, based on diluted earnings per share of $0.04 over the twelve months to Sep 30, 2026.
How much revenue does Solesence make?
Solesence reported revenue of $60.94M for the twelve months to Sep 30, 2026, down 2.0% from a year earlier.
Does Solesence pay a dividend?
No. Solesence has not paid a cash dividend over the last twelve months.
When does Solesence report earnings next?
Solesence is expected to report Q3 FY2026 results on Nov 12, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SLSN stock performed over the past year?
Including dividends, SLSN returned -53.1% over the past year, against +12.0% for the S&P 500.
How many SLSN shares are sold short?
0M shares were sold short at the latest FINRA report, 2.05% of the float, or 19.5 days of average trading volume.
Who are Solesence's competitors?
Companies most similar to Solesence by business, industry and size include AXIL, UG, KARX, MLKMF, YCBD.
See a number that looks wrong?